References
- Kashyap, R. S., A. R. Nayak, A. A. Husain, H. M. Gaherwar, H. J. Purohit, G. M. Taori and H. F. Daginawala. 2013. Tuberculosis in India: the continuing challenge. Curr. Sci. 105: 597-606.
- Husain, A. A., R. S. Kashyap, D. R. Kalorey, S. R. Warke, H. J. Purohit, G. M. Taori, and H. F. Daginawala. 2011. Effect of repeat dose of BCG vaccination on humoral response in mice model. Indian J. Exp. Biol. 49: 7-10.
- Parida, S. K., and S. H. Kaufmann. 2010. Novel tuberculosis vaccines on the horizon. Curr. Opin. Immunol. 22: 374-384. https://doi.org/10.1016/j.coi.2010.04.006
- Hoft, D. F. 2008. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372: 164-175. https://doi.org/10.1016/S0140-6736(08)61036-3
- Morais, F. D., R. S. Rosada, M. O. Paula, P. F. Wowk, L. H. Franco, E. G. Soares, C. L. Silva, and V. L. peron Bonato. 2010. Experimental tuberculosis: designing a better model to test vaccines against tuberculosis. Tuberculosis (Edinb.) 90: 135-142. https://doi.org/10.1016/j.tube.2010.01.005
- Sugawara, I., T. Udagawa, T. Aoki, and S. Mizuno. 2009. Establishment of a guinea pig model of latent tuberculosis with GFP-introduced Mycobacterium tuberculosis. Tohoku J. Exp. Med. 219: 257-262. https://doi.org/10.1620/tjem.219.257
- Srivastava, S., A. Ayyagari, T. N. Dhole, N. Krishnani, K. K. Nyati, and S. K. Dwivedi. 2008. Progression of chronic pulmonary tuberculosis in mice intravenously infected with ethambutol resistant Mycobacterium tuberculosis. Indian J. Med. Microbiol. 26: 342-348. https://doi.org/10.4103/0255-0857.42124
- Fremond, C. M., V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114: 1790-1799. https://doi.org/10.1172/JCI200421027
- Bonanni, D., L. Rindi, N. Lari, and C. Garzelli. 2005. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. J. Med. Microbiol. 54: 443-448. https://doi.org/10.1099/jmm.0.45960-0
- Sharpe, S. A., H. McShane, M. J. Dennis, R. J. Basaraba, F. Gleeson, G. Hall, A. McIntyre, K. Gooch, S. Clark, N. E. Beveridge, E. Nuth, A. White, A. Marriott, S. Dowall, A. V. Hill, A. Williams, and P. D. Marsh. 2010. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin. Vaccine Immunol. 17: 1170-1182. https://doi.org/10.1128/CVI.00079-10
- Gupta, U. D. and V. M. Katoch. 2009. Animal models of tuberculosis for vaccine development. Indian J. Med. Res. 129: 11-18.
- Flynn, J. L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb.) 84: 93-101. https://doi.org/10.1016/j.tube.2003.08.010
- Shekhawat, S. D., R. K Jain, H. M. Gaherwar, H.J. Purohit, G. M. Taori, H. F. Daginawala, and R. S Kashyap. 2014. Heat shock proteins: possible biomarkers in pulmonary and extrapulmonary tuberculosis. Hum. Immunol. 75: 151-158. https://doi.org/10.1016/j.humimm.2013.11.007
- Kolibab, K., A. Yang, M. Parra, S. C. Derrick, and S. L. Morris. 2014. Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines. Clin. Vaccine Immunol. 21: 453-455. https://doi.org/10.1128/CVI.00742-13
- Ottenhoff, T. H., and S. H. Kaufmann. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8: e1002607. https://doi.org/10.1371/journal.ppat.1002607
- Kashyap, R. S., A. R. Nayak, S. Gaikwad, R. K. Jain, H. F. Daginawala, and G. M. Taori. 2013. Biomarkers in pulmonary and extra pulmonary tuberculosis. Proceedings of the International conference on Advances in developing Affordable Invitro molecular Diagnostics. p. 73-86.
- Abebe, F., and G. Bjune. 2009. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 157: 235-243. https://doi.org/10.1111/j.1365-2249.2009.03967.x
- Zuniga, J., D. Torres-Garcia, T. Santos-Mendoza, T. S. Rodriguez-Reyna, J. Granados, and E. J. Yunis. 2012. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin. Dev. Immunol. 2012: 193923.
- Kozakiewicz, L., Y. Chen, J. Xu, Y. Wang, K. Dunussi-Joannopoulos, Q. Ou, J. L. Flynn, S. A. Porcelli, W. R. Jacobs, Jr., and J. Chan. 2013. B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathog. 9: e1003472. https://doi.org/10.1371/journal.ppat.1003472
- Acosta, A., M. N. Norazmi, R. Hernandez-Pando, N. Alvarez, R. Borrero, J. F. Infante, and M. E. Sarmiento. 2011. The importance of animal models in tuberculosis vaccine development. Malays. J. Med. Sci. 18: 5-12.
Cited by
- Heterologous Prime Boost Regimes with N-terminal Peptides of Ag85B Induces Better Protection than Ag85B and BCG in Murine Model of Tuberculosis vol.22, pp.1, 2015, https://doi.org/10.1007/s10989-015-9490-8
- Expression pattern of the autophagy related proteins Beclin1 and LC3B in tuberculous wound tissues vol.19, pp.None, 2015, https://doi.org/10.1177/20587392211024808